QUIRINO, Angela
 Distribuzione geografica
Continente #
NA - Nord America 3.141
AS - Asia 2.293
EU - Europa 1.325
SA - Sud America 612
Continente sconosciuto - Info sul continente non disponibili 169
AF - Africa 49
OC - Oceania 5
Totale 7.594
Nazione #
US - Stati Uniti d'America 3.017
SG - Singapore 1.001
IT - Italia 689
CN - Cina 480
BR - Brasile 455
VN - Vietnam 307
IN - India 195
DE - Germania 175
GB - Regno Unito 111
SE - Svezia 77
FI - Finlandia 74
CA - Canada 72
BD - Bangladesh 71
AR - Argentina 68
HK - Hong Kong 55
NL - Olanda 38
MX - Messico 34
ID - Indonesia 29
CZ - Repubblica Ceca 28
IQ - Iraq 25
FR - Francia 22
EC - Ecuador 20
VE - Venezuela 18
PL - Polonia 17
RU - Federazione Russa 17
TR - Turchia 17
ZA - Sudafrica 16
CL - Cile 14
CO - Colombia 14
JP - Giappone 14
ES - Italia 13
SA - Arabia Saudita 10
UZ - Uzbekistan 10
PE - Perù 9
PK - Pakistan 9
IL - Israele 7
IR - Iran 7
MA - Marocco 7
MT - Malta 7
PY - Paraguay 7
UA - Ucraina 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
DZ - Algeria 6
RO - Romania 6
TH - Thailandia 6
KE - Kenya 5
PH - Filippine 5
SN - Senegal 5
UY - Uruguay 5
AL - Albania 4
AZ - Azerbaigian 4
DK - Danimarca 4
GT - Guatemala 4
HR - Croazia 4
JM - Giamaica 4
JO - Giordania 4
LB - Libano 4
LT - Lituania 4
PT - Portogallo 4
CH - Svizzera 3
CR - Costa Rica 3
EG - Egitto 3
KR - Corea 3
KZ - Kazakistan 3
LV - Lettonia 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
IE - Irlanda 2
KG - Kirghizistan 2
KI - Kiribati 2
KW - Kuwait 2
MN - Mongolia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
AG - Antigua e Barbuda 1
AU - Australia 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
KH - Cambogia 1
LK - Sri Lanka 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
Totale 7.424
Città #
San Jose 669
Singapore 388
Ashburn 318
Chandler 234
Dallas 233
Santa Clara 168
Hefei 151
Bengaluru 150
Milan 128
Munich 114
Ho Chi Minh City 113
Princeton 99
Lawrence 97
Beijing 81
Chicago 79
London 79
Wilmington 63
Hanoi 61
Hong Kong 52
Turku 52
Los Angeles 49
Boardman 44
Rome 43
São Paulo 43
Catanzaro 38
Ottawa 38
New York 33
Des Moines 27
Palermo 26
Florence 23
Naples 22
Olomouc 21
Helsinki 20
Council Bluffs 17
Haiphong 16
Crotone 15
Brooklyn 13
Da Nang 13
Montreal 13
Norwalk 12
Salvador 12
Shanghai 12
Tokyo 12
Warsaw 12
Belo Horizonte 11
Chennai 11
San Francisco 11
Baghdad 10
Biên Hòa 10
Boston 10
Guayaquil 10
Mexico City 10
San Nicola Manfredi 10
Tashkent 10
Brasília 9
Catania 9
Padova 9
Amsterdam 8
Assago 8
Buffalo 8
Cosenza 8
Dhaka 8
Taranto 8
Toronto 8
Curitiba 7
Guangzhou 7
Hanover 7
Ninh Bình 7
Phoenix 7
Redmond 7
Redwood City 7
Rio de Janeiro 7
Santiago 7
The Dalles 7
Aversa 6
Bari 6
Buenos Aires 6
Cape Town 6
Caracas 6
Columbus 6
Erbil 6
Guarulhos 6
Lima 6
Lấp Vò 6
Manchester 6
Maryland Heights 6
Miami 6
Porto Alegre 6
Quito 6
Shenzhen 6
St Louis 6
Thái Bình 6
Can Tho 5
Casalnuovo di Napoli 5
Dakar 5
Fortaleza 5
Jakarta 5
Johannesburg 5
Orem 5
Pune 5
Totale 4.307
Nome #
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 136
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-independent and associated with an increase of CD25(+) cells 133
An unusual case of brain abscess by Gemella morbillorum 131
Anti-inflammatory effect of procalcitonin on in vitro LPS-stimulated human PBMC 122
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 109
The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives 96
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 93
A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis 83
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 78
Ochrobactrum anthropi 78
Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery 78
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 77
COVID-19 Vaccine Booster Shot Preserves T Cells Immune Response Based on Interferon-Gamma Release Assay in Inflammatory Bowel Disease (IBD) Patients on Anti-TNFα Treatment 76
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital 74
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN COVID-19 PATIENTS 73
Antimicrobial resistance in pathogens isolated from blood cultures: A two-year multicenter hospital surveillance study in Italy 70
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 68
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 68
Citrus bergamia: Kinetics of Antimicrobial Activity on Clinical Isolates 68
APPLICATIONS OF LIGHTCYCLER STAPHYLOCOCCUS MGRADE ASSAY TO DETECT S. AUREUS AND COAGULASE-NEGATIVE STAPHYLOCOCCI IN CLINICAL BLOOD SAMPLES AND IN BLOOD CULTURE BOTTLES. 67
JANUS FACE BARTONELLA QUINTANA RECOGNITION BY TOLL-LIKE RECEPTORS (TLR): A REVIEW 67
Are SARS-CoV-2 rapid antigen tests useful for the control of latest variants spreading? 66
BARTONELLA QUINTANA LIPOPOLYSACCHARIDE EFFECTS ON LEUKOCYTES, CXC CHEMOKINES AND APOPTOSIS: A STUDY ON THE HUMAN WHOLE BLOOD AND A RAT MODEL 66
Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series. 66
Bartonella quintana lipopolysaccharide effects on leukocytes, CXC chemokines and apoptosis: a study on the human whole blood ans a rat model. 65
SARS-CoV-2: Some Aspects of Molecular Evolution, Cellular Pathogenesis, and Immune System Mechanism Elusion 65
Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes 65
Temperature-dependent regulation of the Ochrobactrum anthropi proteome 64
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report. 64
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience 63
Control of carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit of a teaching hospital in Southern Italy 61
APPLICATIONS OF LIGHTCYCLER STAPHILOCOCCUS MGRADE ASSAY TO DETECT Staphylococcus aureus AND COAGULASE-NEGATIVE STAPHILOCOCCI IN CLINICAL BLOOD SAMPLES AND IN BLOOD CULTURE BOTTLES 61
Shotgun proteomic analysis of two Bartonella quintana strains 61
Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19? 60
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection 60
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy 60
Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study 59
Depression of lymphocyte activity during cutaneous leishmaniasis: a case report. 59
Listeria infection after treatment with alemtuzumab: A case report and literature review. would antibiotic prophylaxis be considered? 59
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report 57
Role of IgG and IgM and proinflammatory aspecific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 57
Quirino A, Morelli P, Capua G, Arena G, Matera G, Liberto MC, Focà A. Synergistic and antagonistic effects of Citrus bergamia distilled extract and its major components on drug resistant clinical isolates. 56
Virological Mechanisms in the Coinfection between HIV and HCV 55
Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: a 5-year cross-sectional retrospective study and a literature review 54
AN ATYPICAL PATTERN OF HCV INNO-LiPA SUBTYPE 54
An Ascaris lumbricoides infection diagnosed by colonoscopy: A case report and a brief literature review 53
A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment 53
In Vitro Antimicrobial Activity of Natural Essence and Distilled Extract of Bergamot against Drug Resistance Clinical Isolates 53
In vitro Bartonella quintana infection modulates the programmed cell death and inflammatory reaction of endothelial cells 53
Fast-track ruling in/out SARS-CoV-2 infection with rapid 0/1.5 h molecular test in patients with acute coronary syndromes 53
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-indipendent and associated with an increase of CD25+ cells 51
Chronic neuroborreliosis by B. garinii: an unusual case presenting with epilepsy and multifocal brain MRI lesions 51
Impact of Multiplex PCR on Diagnosis of Bacterial and Fungal Infections and Choice of Appropriate Antimicrobial Therapy. 50
Prevalence of Enteric Pathogens and Antibiotic Resistance: Results of a Six-Year Active Surveillance Study on Patients Admitted to a Teaching Hospital 50
The issue of climate change and the spread of tropical diseases in Europe and Italy: vector biology, disease transmission, genome-based monitoring and public health implications. 50
Cellular mediators in human leishmaniasis: Critical determinants in parasite killing or disease progression 50
Identification of pmrB mutations as putative mechanism for colistin resistance in A. baumannii strains isolated after in vivo colistin exposure. 50
SOLUBLE CD14 SUBTYPE - A NEW BIOMARKER IN PREDICTING OUTCOME OF CRITICALLY ILL SEPTIC PATIENTS: AN OBSERVATIONAL PROSPECTIVE STUDY. 49
Stenotrophomonas maltophilia lipopolysaccharide (LPS) and antibiotics: "in vitro" effects on inflammatory mediators 49
Integrating Digital Health Solutions with Immunization Strategies: Improving Immunization Coverage and Monitoring in the Post-COVID-19 Era 48
Changing and Evolution of Influenza Virus: Is It a Trivial Flu? 48
Coupled plasma filtration adsorption for the treatment of a patient with acute respiratory distress syndrome and acute kidney injury: a case report 48
Increase of Vascular Endothelial Growth Factor and Decrease of MCP-1 and Some Updated Epidemiology Aspects of Cystic Echinococcosis Human Cases in Calabria Region 48
Synergistic and antagonistic effects of Citrus bergamia distilled extract and its major components on drug resistant clinical isolates 48
Applications of LightCycler Staphylococcus M-GRADE assay to detect Staphylococcus aureus and coagulase-negative staphylococci in clinical blood samples and in blood culture bottles 48
Molecular characterization of autochthonous Hepatitis E virus detected from a human acute infection in the Calabria Region, Southern Italy 47
INTERLEUKIN-62/LYMPHOCYTE AS A PROPOSED PREDICTIVE INDEX FOR COVID-19 PATIENTS TREATED WITH MONOCLONAL ANTIBODIES 46
Efflux Pump AdeABC Assessment in Acinetobacter baumannii Strains Isolated in a Teaching Hospital 46
Inhibition of neutrophil apoptosis after coronary bypass operation with cardiopulmonary 46
Impact of interleukin-10, soluble CD25 and interferon-γ on the prognosis and early diagnosis of bacteremic systemic inflammatory response syndrome: a prospective observational study 46
Characterization of SARS-CoV-2 Variants in Military and Civilian Personnel of an Air Force Airport during Three Pandemic Waves in Italy 45
Microbiological and Clinical Findings of SARS-CoV-2 Infection after 2 Years of Pandemic: From Lung to Gut Microbiota 45
Utility of Molecular Identification and Quantitation of Bartonella Species with Species-Specific Real-Time PCR for Monitoring Treatment Response: A Case Series. 45
CYTOKINE MILIEU AND NITRITE RELEASE DURING EARLY CHALLENGE OF HUMAN PBMC BY LEISHMANIA INFANTUM AND LEISHMANIA MAJOR 45
Phylogenetic and Molecular Analyses of More Prevalent HCV1b Subtype in the Calabria Region, Southern Italy 45
Whole-genome analysis of SARS-CoV-2 in a 2020 infection cluster in a nursing home of Southern Italy 45
Clostridioides difficile Infection: Use of Inflammatory Biomarkers and Hemogram-Derived Ratios to Predict Mortality Risk in Hospitalized Patients 44
IL-35 soluble CD14 subtype might be useful prognostic markers in critical septic patients 44
Phenotypic and genotypic evaluation of slime production by conventional and molecular microbiological techniques 44
Interleukin-62/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies 43
Orthopedic Device-Related Infections Due to Emerging Pathogens Diagnosed by a Combination of Microbiological Approaches: Case Series and Literature Review 43
Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study 43
Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges. 43
Procalcitonin, IL-10 and sCD25 as diagnostic and prognostic markers in critically ill patients 43
Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma 42
Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients. 42
Bartonella quintana-induced apoptosis inhibition of human endothelial cells is associated with p38 and SAPK/JNK modulation and with stimulation of mitosis 42
In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience 41
The Spread of SARS-CoV-2 Omicron Variant in CALABRIA: A Spatio-Temporal Report of Viral Genome Evolution 41
Does the Human Gut Virome Contribute to Host Health or Disease? 41
Prevalence of Colonization with Multidrug-Resistant Bacteria: Results of a 5-Year Active Surveillance in Patients Attending a Teaching Hospital 41
Prevalence of parasitic infections in migrants: do official symptom-driven guidelines apply to the current situation? 41
BARTONELLAE: STEALTHY PATHOGENS OR NOVEL DRUGS FACTORIES 41
Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study (BMC Infectious Diseases, (2022), 22, 1, (793), 10.1186/s12879-022-07774-9) 40
PATOGENI INUSUALI: PATOGENESI E DIAGNOSTICA DI BARTONELLA 40
IN VITRO BARTONELLA QUINTANA INFECTION MODULATES THE PROGRAMMED CELL DEATH AND INFIAMMATORY REACTION OF ENDOTHELIAL CELLS 40
MULTIPLE ABSCESSES OF THE LEFT BRAIN HEMISPHERE DUE TO LISTERIA MONOCYTOGENES IN IMMUNOCOMPROMISED PATIENT: A CASE REPORT. 40
Risk factors for the development of hospital-acquired pneumonia in patients with carbapenem-resistant Acinetobacter baumannii respiratory colonization and the role of multisite colonization: a multicenter retrospective study. 39
Eleven-Year Distribution Pattern of Hepatitis C Virus in Southern Italy 39
Role of IgG and IgM and proinflammatory non-specific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 39
Totale 5.802
Categoria #
all - tutte 66.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022286 0 1 0 68 15 6 26 63 24 19 60 4
2022/2023740 205 66 20 64 58 57 19 38 94 36 67 16
2023/2024560 81 75 23 40 50 110 15 27 19 23 39 58
2024/20251.657 214 67 66 79 138 177 46 59 186 58 224 343
2025/20264.032 229 426 432 670 367 181 461 251 435 322 142 116
2026/202754 54 0 0 0 0 0 0 0 0 0 0 0
Totale 7.594